These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 420204)

  • 1. Economics of hospital pharmacy practice. I. Third-party reimbursement.
    Zellmer WA
    Am J Hosp Pharm; 1979 Feb; 36(2):169. PubMed ID: 420204
    [No Abstract]   [Full Text] [Related]  

  • 2. Third-party reimbursement for clinical pharmacy services.
    Riddiough MA
    Am J Hosp Pharm; 1978 Jan; 35(1):18, 20. PubMed ID: 623110
    [No Abstract]   [Full Text] [Related]  

  • 3. A fee for the service of pharmacy: the time has come.
    Tanner DJ
    Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821
    [No Abstract]   [Full Text] [Related]  

  • 4. Hospital reimbursement and clinical pharmacy programs.
    Hoffmann RP
    Hosp Pharm; 1979 Dec; 14(12):723, 726-7. PubMed ID: 10244960
    [No Abstract]   [Full Text] [Related]  

  • 5. Third-party reimbursement for clinical pharmacy services: philosophy and practice.
    Nold EG; Pathak DS
    Am J Hosp Pharm; 1977 Aug; 34(8):823-6. PubMed ID: 900133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The piggyback dilemma.
    Tanner DJ
    Hosp Pharm; 1978 Jun; 13(6):326. PubMed ID: 10307644
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations in establishing fees for home-care pharmaceutical services.
    Mirtallo JM
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S15-7. PubMed ID: 2672803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASHP statement on third-party compensation for clinical services by pharmacists.
    Am J Hosp Pharm; 1985 Jul; 42(7):1580-1. PubMed ID: 4025361
    [No Abstract]   [Full Text] [Related]  

  • 9. Payment for nondistributive hospital pharmacy services--a regional survey.
    Strandberg LR; Stennett DJ; Simonson W
    Drug Intell Clin Pharm; 1978 Jul; 12(7):410-2. PubMed ID: 10308024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics of hospital pharmacy practice. II: charging for services.
    Zellmer WA
    Am J Hosp Pharm; 1979 Mar; 36(3):307-8. PubMed ID: 420222
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacy and Blue Cross Plans: reimbursement and support of innovative pharmacy programs.
    Touquan S
    Hosp Pharm; 1977 Jan; 12(1):22-4, 26. PubMed ID: 10305421
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical services in a third-party system: an analysis.
    Donehew GR
    Contemp Pharm Pract; 1981; 4(4):246-52. PubMed ID: 10256900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement for nondistributive pharmaceutical services in hospitals.
    Oakley RS; McCormick WC
    Am J Hosp Pharm; 1982 Apr; 39(4):594-9. PubMed ID: 7044116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-party payer reimbursement for patient education and pharmacokinetic dosing services.
    Nold EG
    Am J Hosp Pharm; 1978 Nov; 35(11):1337. PubMed ID: 707495
    [No Abstract]   [Full Text] [Related]  

  • 15. Financing hospitals and clinical pharmacy services.
    Lash MP
    Hosp Pharm; 1980 Feb; 15(2):78-88. PubMed ID: 10245491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the rules of the reimbursement game.
    Curtiss FR
    Am J Hosp Pharm; 1982 Nov; 39(11):1975-7. PubMed ID: 7148872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reimbursement of clinical pharmacy services in community hospitals and nursing homes.
    Sisca TS
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):64-8. PubMed ID: 3545738
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence and response to the impact of the Medicaid Drug Rebate Program (OBRA) on hospital pharmacy: a progress report from central Ohio.
    Taylor S; Kucukarslan S; Sherrin T
    Hosp Pharm; 1991 Jul; 26(7):621, 624-5. PubMed ID: 10111796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.